| Entry |
|
|---|
| Name |
Latrepirdine (USAN/INN) |
|---|
| Formula |
C21H25N3
|
|---|
| Exact mass |
319.2048
|
|---|
| Mol weight |
319.4433
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01595 Cholinesterase inhibitor
DG01593 Acetylcholinesterase inhibitor
DG01498 NMDA receptor antagonist
DG01968 Agents for Alzheimer-type dementia
|
|---|
| Remark |
|
|---|
| Efficacy |
Dementia therapeutic agent, Acetylcholinesterase inhibitor, NMDA receptor antagonist |
|---|
| Comment |
Treatment of Alzheimer's disease
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07056 | Agents for Alzheimer-type dementia |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Glutamate (ionotropic), NMDA
GRIN (NMDAR)
D09917 Latrepirdine (USAN/INN)
Enzymes
Hydrolases (EC3)
Carboxylic-ester hydrolases
ACHE
D09917 Latrepirdine (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 24
1 C8y C 19.9065 -28.4433
2 C8y C 21.3057 -28.3959
3 C8y C 21.6930 -27.0505
4 N4y N 20.5331 -26.2664
5 C8y C 19.4290 -27.1272
6 C8x C 22.2771 -29.4040
7 C8y C 23.6359 -29.0667
8 C8x C 24.0232 -27.7213
9 C8x C 23.0517 -26.7132
10 C1x C 18.0505 -26.8826
11 C1x C 17.1495 -27.9541
12 N1y N 17.6270 -29.2702
13 C1x C 19.0054 -29.5148
14 C1b C 20.4855 -24.8502
15 C1b C 21.6913 -24.0987
16 C8y C 21.7134 -22.6811
17 C8x C 22.9268 -22.0054
18 N5x N 22.9485 -20.6056
19 C8y C 21.7470 -19.8869
20 C8x C 20.5336 -20.5626
21 C8x C 20.5119 -21.9624
22 C1a C 21.7687 -18.4800
23 C1a C 24.6103 -30.0780
24 C1a C 16.7364 -30.3293
BOND 27
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 1
5 1 5 2
6 2 6 1
7 6 7 2
8 7 8 1
9 8 9 2
10 3 9 1
11 5 10 1
12 10 11 1
13 11 12 1
14 12 13 1
15 1 13 1
16 4 14 1
17 14 15 1
18 15 16 1
19 16 17 1
20 17 18 2
21 18 19 1
22 19 20 2
23 20 21 1
24 16 21 2
25 19 22 1
26 7 23 1
27 12 24 1
|
|---|
